Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme

Author:

Kulothungan Vaitheeswaran,Ramamoorthy Thilagavathi,Sathishkumar Krishnan,Mohan Rohith,Tomy Nifty,Miller G. J.,Mathur PrashantORCID

Abstract

Abstract Purpose Female breast cancer (BC) is the leading cause of cancer incidence and mortality in India, and accounted for 13.5% of new cancer cases and 10% of cancer-related deaths in 2020. This study aims to estimate and report the female BC burden in India at state level from 2012 to 2016 in terms of years of life lost, years lived with disability, and disability-adjusted life years (DALYs), and to project the burden for the year 2025. Methods The cancer incidence and mortality data from 28 population-based cancer registries were analysed. The mean mortality to incidence ratio was estimated, and mortality figures were adjusted for underreporting. The burden of female BC was estimated at national and subnational levels using Census data, World Health Organisation’s lifetables, disability weights, and the DisMod-II tool. A negative binomial regression is employed to project burden for 2025. Results The burden of BC among Indian women in 2016 was estimated to be 515.4 DALYs per 100,000 women after age standardization. The burden metrics at state level exhibited substantial heterogeneity. Notably, Tamil Nadu, Telangana, Karnataka, and Delhi had a higher burden of BC than states in the eastern and north-eastern regions. The projection for 2025 indicates to a substantial increase, reaching 5.6 million DALYs. Conclusion The female BC burden in India was significantly high in 2016 and is expected to substantially increase. Undertaking a multidisciplinary, context-specific approach for its prevention and control can address this rising burden.

Publisher

Springer Science and Business Media LLC

Reference47 articles.

1. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelaim A et al (2019) Global burden of disease cancer collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749–68. https://doi.org/10.1001/jamaoncol.2019.2996

2. World Health Organisation (2021) The global cancer observatory, source: Globocan 2020, 356-india-fact-sheets.pdf. Factsheet-India. World Health Organisation. https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf. Accessed 17 Jan 2023

3. Nandakumar A, Rath GK, Kataki AC, Bapsy PP, Gupta PC, Gangadharan P et al (2016) Decreased survival with mastectomy Vis-à-vis breast-conserving surgery in stage II and III breast cancers: a comparative treatment effectiveness study. J Glob Oncol 3(4):304–313. https://doi.org/10.1200/JGO.2016.004614

4. Mathew A, George PS, Kunnambath R, Mathew BS, Kumar A, Syampramod R, Booth CM (2020) Educational status, cancer stage, and survival in South India: a population-based study. JCO Glob Oncol 6:1704–1711. https://doi.org/10.1200/GO.20.00259

5. Kulothungan V, Sathishkumar K, Leburu S, Ramamoorthy T, Stephen S, Basavarajappa D et al (2022) Burden of cancers in India–estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on national cancer registry program. BMC Cancer 22(1):527. https://doi.org/10.1186/s12885-022-09578-1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3